Max Dawson
Direttore operativo presso DermBiont, Inc.
Profilo
Max N.
Dawson is currently the Chief Operating Officer at DermBiont, Inc. He previously worked as the Head-Program Finance at Vertex Pharmaceuticals, Inc., an Analyst-Finance & Operations at Merck KGaA, the Head-Business Development at Dyax Corp., and the Vice President-Business Development at Adagene, Inc. He holds an MBA from Babson College and an undergraduate degree from Bates College.
Posizioni attive di Max Dawson
| Società | Posizione | Inizio |
|---|---|---|
DermBiont, Inc.
 DermBiont, Inc. Miscellaneous Commercial ServicesCommercial Services DermBiont, Inc. operates as an early stage biopharmaceutical company that engages in discovery and development of live bacterial products for the treatment of skin diseases. It develops skin microbiome therapeutics platform to treat and prevent skin diseases. The company was founded by Karl R. Beutner, Robert M. Brucker and Nichola Eliovits in 2017 and is headquartered in Boston, MA. | Direttore operativo | 01/09/2019 |
Precedenti posizioni note di Max Dawson
| Società | Posizione | Fine |
|---|---|---|
| MERCK KGAA | Corporate Officer/Principal | - |
| DYAX CORP. | Corporate Officer/Principal | - |
| VERTEX PHARMACEUTICALS INCORPORATED | Corporate Officer/Principal | - |
| ADAGENE INC. | Corporate Officer/Principal | - |
Formazione di Max Dawson
| Babson College | Masters Business Admin |
| Bates College | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 3 |
|---|---|
| ADAGENE INC. | Health Technology |
| VERTEX PHARMACEUTICALS INCORPORATED | Health Technology |
| MERCK KGAA | Health Technology |
| Aziende private | 2 |
|---|---|
Dyax Corp.
 Dyax Corp. Pharmaceuticals: MajorHealth Technology Dyax Corp. engages in discovery, development and commercialization of novel biotherapeutics. The company was founded by Henry E. Blair in 1989 and is headquartered in Burlington, MA. | Health Technology |
DermBiont, Inc.
DermBiont, Inc. Miscellaneous Commercial ServicesCommercial Services DermBiont, Inc. operates as an early stage biopharmaceutical company that engages in discovery and development of live bacterial products for the treatment of skin diseases. It develops skin microbiome therapeutics platform to treat and prevent skin diseases. The company was founded by Karl R. Beutner, Robert M. Brucker and Nichola Eliovits in 2017 and is headquartered in Boston, MA. | Commercial Services |
- Borsa valori
- Insiders
- Max Dawson
